Neste grupo esto alguns hormnios, medicamentos para diabetes, obesidade e algumas terapias voltadas para doenas raras
It therefore follows that BPC 157 is a novel cytoprotection mediator, one that is very safe and showed no side effects in clinical trials (i.e., in use for ulcerative colitis), and wherein a lethal dose (LD1) was not achieved in toxicology studies (for review, see [1,9,33,93])
Of note, improvements in glycemic control, blood pressure, and lipid profile have been identified, which may lead to a reduction or delay in disease progression
It supports follicle repair, increases blood flow, reduces inflammation, and helps extend the growth phase
IL-4 and Th2 cell production are increased after mast cell degranulation